FindTrial
Sign In

Detection of familial cancer risk in Indian men with prostate cancer.

Diagnosing hereditary cancer predisposition in Indian men with prostate cancer: a pilot study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030180
Enrollment
50
Registered
2021-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Control Intervention1: Nil: Nil

Sponsors

AIIMS Intramural Fund
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Histo-pathologically proven case of adeno-carcinoma prostate with either regional (node-positive) or metastatic disease.

Exclusion criteria

Exclusion criteria: Patients will be excluded from this study if: 1. he has physical, cognitive or psychiatric conditions that interfere with the ability to give informed consent; 2. he is less than 18 years of age.

Design outcomes

Primary

MeasureTime frame
Frequency of pathogenic or likely pathogenic(p/LP) germline mutations in the cohort.Timepoint: 2 years—

Secondary

MeasureTime frame
Correlation of pathogenic or likely pathogenic mutations with Clinical features, Gleason-scores and family historyTimepoint: 2 years—

Countries

India

Contacts

Public ContactRaja Pramanik

All India Institute of Medical Sciences, New Delhi

drrajapramanik@gmail.com9654976088

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026